Veracyte reported $0.54 in EPS Earnings Per Share for its fiscal quarter ending in June of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.43 0.51 Nov/10
FY2026Q2 Jun/2026 0.54 0.43 0.44 Jul/30
FY2026Q1 Mar/2026 0.52 0.34 0.31 May/05
FY2024Q4 Dec/2025 0.53 0.39 0.36 Feb/25
FY2025Q3 Sep/2025 0.51 0.32 0.33 Nov/04




Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
Agilent USD 1.43 0.11 Mar/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
Bruker USD 0.49 0.18 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Illumina USD 1.31 0.16 Jun/2026
Intrexon USD -0.1 0.03 Jun/2024
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Laboratory Of America USD 4.99 0.74 Jun/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
Myriad Genetics USD -0.25 0.16 Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Siemens EUR 2.93 0.48 Jun/2026
Sonic Healthcare AUD 0.53 0.04 Dec/2025
Thermo Fisher Scientific USD 6.03 0.59 Jun/2026
Veracyte USD 0.54 0.02 Jun/2026
Waters USD 3.05 0.35 Jun/2026